[TVTX] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[TVTX] Travere Therapeutics, Inc.
Announcement Date
07-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- 276.03%
YoY- 316.40%
Quarter Report
TVTX's Result
TVTX's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 54,116 41,374 45,059 37,095 59,697 56,993 55,868 -2.10%
PBT -69,567 -135,767 -88,528 -89,229 -85,565 -86,253 -65,760 3.82%
Tax 85 191 68 -12 65 78 63 22.12%
NP -70,409 -136,061 -90,173 150,735 -85,630 -86,331 -65,823 4.59%
Tax Rate - - - - - - - -
Total Cost 124,525 177,435 135,232 -113,640 145,327 143,324 121,691 1.54%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin -130.11 -328.86 -200.12 406.35 -143.44 -151.48 -117.82 6.84%
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -0.91 -1.76 -1.18 -0.99 -1.13 -1.27 -1.03 -7.93%
EPS Diluted -0.91 -1.76 -1.18 -0.99 -1.13 -1.27 -1.03 -7.93%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.